WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2012 sales and earnings conference call with institutional investors and analysts at 8 a.m. EDT on Friday, July 27. During the call, Kenneth C. Frazier, chairman and chief executive officer, Peter N. Kellogg, executive vice president and chief financial officer, and Adam H. Schechter, president, Global Human Health, will provide an overview of Merck’s financial performance for the quarter.
